Company / Cash per Share
Emergent BioSolutions Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.94
FY2025
5-year range
$1.83 / $12.53
FY2021-FY2025
Trend
+115.1%
vs FY2024
Sector context
#51 of 205
Health Care
What the data says
Emergent BioSolutions Inc.'s cash per share of $3.94 is higher than 75% of companies in the Health Care sector (FY2025). Cash per Share returned to growth in FY2025 after 2 years of decline, reaching $3.94.
Based on SEC 10-K filings.
3.94 in FY2025 with a 5-year CAGR of -20.0%. Top quartile in the Health Care sector.
Improved from $2.14 to $3.94 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -32.0%
- 5-Year CAGR
- -20.0%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 205This company $3.94 Sector average $72.93
▼
-94.6% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 115.1% year-over-year.
- Ranks #51 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2022.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.94 | +115.1% |
| FY2024 | $1.83 | -14.4% |
| FY2023 | $2.14 | -82.9% |
| FY2022 | $12.53 | +11.5% |
| FY2021 | $11.23 | -6.6% |
| FY2020 | $12.02 | +270.3% |
| FY2019 | $3.25 | -10.1% |
| FY2018 | $3.61 | -17.9% |
| FY2017 | $4.39 | -36.2% |
| FY2016 | $6.89 | -16.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026